EBIT: Income before interest and taxes.
Rocket Pharmaceuticals, Inc. (RCKT) had EBIT of $-43.96M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-42.54M |
|
-- |
|
-- |
|
$43.96M |
|
$-43.96M |
|
$1.43M |
|
$-42.54M |
|
$-42.54M |
|
$-42.54M |
|
$-42.54M |
|
$-42.54M |
|
$-42.54M |
|
|
EBIT |
$-43.96M |
$-41.48M |
|
111.12M |
|
111.12M |
|
$-0.38 |
|
$-0.38 |
|
| Balance Sheet Financials | |
$192.73M |
|
$28.17M |
|
$137.72M |
|
$330.45M |
|
$30.21M |
|
$19.36M |
|
$23.02M |
|
$53.23M |
|
$277.22M |
|
$212.92M |
|
$277.22M |
|
108.32M |
|
| Cash Flow Statement Financials | |
$-190.01M |
|
$103.77M |
|
$0.15M |
|
$165.00M |
|
$78.90M |
|
$-86.10M |
|
$37.06M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.38 |
|
-- |
|
-- |
|
0.07 |
|
0.08 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-190.45M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-15.34% |
|
-19.98% |
|
-12.87% |
|
-14.34% |
|
$2.56 |
|
$-1.71 |
|
$-1.71 |
|